Analysis WellQuest Medical & Wellness Corp. (WEQL)
5/26/2024
Analysis of WellQuest Medical & Wellness Corp. (WEQL)
WellQuest Medical & Wellness Corp. (WEQL) has been trading at a consistent price of 0.00010 over the past several days, with no significant changes in indicators such as RSI, MACD, and moving averages (SMA, EMA, WMA). This stability may indicate a lack of significant market activity or investor interest in the stock at the moment.It is important to note that this analysis is based on historical data and does not take into account any external factors or news that may impact the stock price in the future. Traders and investors should conduct further research and analysis before making any decisions regarding WellQuest Medical & Wellness Corp.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2021.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance and payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. The company's net income has been relatively stable, with fluctuations in other non-cash items such as depreciation and stock-based compensation.
8. Overall, the company's cash flow statement reflects a mix of stability in operating activities and variability in financing and investing activities over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing growth compared to the previous year's EPS, indicating a positive outlook for the company's financial performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an average annual growth rate of 11%.
- However, in the past 5 years, the company has experienced a higher average annual growth rate of 20.1%.
Overall, the company is expected to maintain a solid growth trajectory in the coming years, with a slightly lower growth rate in the short term compared to the long-term average.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it seems that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty in the predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided yet. The previous results, ending on February 27, 2025, are with the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not supplied at the time. The results from August 1, 2024, showed an EPS estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating good financial performance. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 31, 2024. The company shows a solid return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the stock's performance over the past year, including its beta, moving averages, and the range between the fifty-two-week low and high.
Valuations metrics reveal the company's valuation multiples, such as P/E ratios, price to book, price to sales, and enterprise value multiples. The market capitalization is also provided.
Lastly, dividends and splits information includes details on dividend rates, payout ratios, dividend dates, and historical split information for the company.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2020: Sales of $274,515,000,000
2. Fiscal Year 2021: Sales of $365,817,000,000
3. Fiscal Year 2022: Sales of $394,328,000,000
4. Fiscal Year 2023: Sales of $383,285,000,000
From these figures, we can observe the following trends:
- There was a steady increase in sales from 2020 to 2022, with a slight decrease in 2023.
- The company experienced significant growth in revenue between 2020 and 2022, indicating positive performance.
- Despite a slight dip in sales in 2023, the overall revenue trend shows a positive trajectory over the four-year period.
These insights can help in assessing the company's financial performance and making informed decisions regarding future strategies.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been investing more in non-current assets over the years, which could indicate long-term growth strategies.
7. The company has been relying more on long-term debt to finance its operations, as seen in the increasing trend of non-current liabilities.
8. Overall, the company's financial position seems stable, with a healthy balance between assets, liabilities, and shareholders' equity.
MACD of WEQL
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
